The cisplatin-methotrexate neo-adjuvant protocol as first-line therapy of bladder cancer. Present experience in Palermo

Prog Clin Biol Res. 1988:260:579-83.
No abstract available

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Transitional Cell / drug therapy*
  • Carcinoma, Transitional Cell / surgery
  • Cisplatin / administration & dosage
  • Combined Modality Therapy
  • Humans
  • Methotrexate / administration & dosage
  • Preoperative Care
  • Urinary Bladder Neoplasms / drug therapy*
  • Urinary Bladder Neoplasms / surgery

Substances

  • Cisplatin
  • Methotrexate